The Elephant in the Room: Secondary Infections and Antimicrobial Use in Patients With COVID-19
Chest
.
2021 Aug;160(2):387-388.
doi: 10.1016/j.chest.2021.04.053.
Authors
Marco Ripa
1
,
Andrea Mastrangelo
2
Affiliations
1
Unit of Infectious and Tropical Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address: ripa.marco@hsr.it.
2
Vita-Salute San Raffaele University, Milan, Italy.
PMID:
34366018
PMCID:
PMC8339425
DOI:
10.1016/j.chest.2021.04.053
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anti-Bacterial Agents / therapeutic use
Anti-Infective Agents* / therapeutic use
COVID-19*
Coinfection* / drug therapy
Humans
SARS-CoV-2
Substances
Anti-Bacterial Agents
Anti-Infective Agents